Tuesday 16 June |
Marshall Motor |
Clearstar |
Epwin Group |
Coca-Cola HBC |
Science Group |
Altus Strategies |
Arbuthnot Banking |
Evraz |
Andrews Sykes Group |
FDM Group |
Wednesday 17 June |
Amigo Holdings (re board removal) |
RTC Group |
Wentworth Resources |
STM Group |
Salt Lake Potash |
Domino's Pizza Group |
Pelatro |
UK Oil & Gas |
G4S |
Thursday 18 June |
Ted Baker (re share placing) |
IP Group |
Horizon Discovery |
Ten Entertainment |
Shield Therapeutics |
Tremor International |
Jadestone Energy |
Vietnam Enterprise |
Intelligent Ultrasound Group |
Block Energy |
RBG Holdings |
Impact Healthcare |
Michelmersh |
Immupharma |
Friday 19 June |
boohoo |
Power Metal Resources |
Costain Group |
Learning Technologies Group |
John Wood Group |
Trinty Exploration |
AA |
Monday 22 June |
Ethernity Networks |
SAGA |
Wincanton |
Avacta |
President Energy |
Copyright 2020 Alliance News Limited. All Rights Reserved. |
IN BRIEF: Avacta picks Christina Coughlin to replace long-serving CEO
Avacta Group PLC - Wetherby, West Yorkshire-based life sciences company developing cancer treatments and diagnostics - Promotes Christina Coughlin to chief executive officer from head of Research & Development. Coughlin has been an Avacta board member since March 2022 and head of R&D since this past February. She replaces Alastair Smith, who steps down on Tuesday after 19 years as CEO. Coughlin was CEO of Cytolmmune Therapeutics, which develops cell therapy solutions from a facility in Puerto Rico. She also has worked at Pfizer Inc and Novartis AG.
Read more